Why it matters
The recall may affect U.S. patients and pharmacies that have the recalled tablets. The article does not identify the impurity, affected lots, or the health risk.
DRUGS, DEVICES & RECALLS • UNITED STATES
Blood pressure drug combination recalled over an impurity
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
BLUF
A recall covers combined amlodipine and olmesartan medoxomil tablets because of an impurity, according to The Epoch Times. The article says thousands of bottles are affected but provides no further recall details.
HOW THIS BRIEF WAS MADE 1 outlet: 1 national. Automated sourcing and summaries by the BLUF engine. Corrections